Stay updated on Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2; the rest of the page content appears unchanged.SummaryDifference0.1%

- Check20 days agoChange DetectedFooter revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedGlossary visibility has been added to the page. Footer and header labels were updated to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while older labels such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. This is a minor site version update that does not affect the page content or user actions; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA dedicated Locations section has been added and site listings updated to include California, Florida, Ohio, Texas, and Ontario. The previous per-location subsections were removed and the page revision updated to v3.3.3.SummaryDifference0.6%

- Check91 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this is a minor metadata update with no changes to the study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page.